MedTrace Logo

Bilateral Occipital Nerve Field Stimulation for the Treatment of dtCCH

NCT06124534 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-06-26

No results posted yet for this study

Summary

The purpose of this study is to assess the initial safety, tolerability, and effectiveness of the novel BliStim occipital nerve field stimulation therapy for the prevention of chronic cluster headaches. This is a prospective, first in human study.

Conditions

  • Chronic Cluster Headache

Interventions

DEVICE

Neurostimulation of the Occipital Nerve Field

BliStim Neurostimulation system

Sponsors & Collaborators

  • Man and Science, SA

    lead INDUSTRY

Principal Investigators

  • J-P Van Buyten · VITAZ Hospital, Sint Niklaas, Belgium

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-19
Primary Completion
2024-11-21
Completion
2025-03-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124534 on ClinicalTrials.gov